0.5 ML golimumab 100 MG/ML Prefilled Syringe [Simponi] — RxCUI 848164
RxNorm drug concept · Semantic branded drug
RxCUI 848164
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI848164
Official name0.5 ML golimumab 100 MG/ML Prefilled Syringe [Simponi]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as0.5 ML Simponi 100 MG/ML Prefilled Syringe; Simponi 50 MG in 0.5 mL Prefilled Syringe; Simponi 50 MG per 0.5 ML Prefilled Syringe
FDA products mapped2
Package NDCs mapped8
Reported Medicaid activity (SDUD)7,943 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Golimumab Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Golimumab is approved for several inflammatory conditions, and which ones depend on the product you're using. Simponi — the version you inject under your own skin — treats rheumato...
- What conditions does golimumab actually treat?
- Before injecting, take the prefilled syringe or autoinjector out of the refrigerator and let it sit at room temperature for at least 30 minutes — don't try to warm it up any other...
- How do I give myself the Simponi injection at home?
🕸️ Concept Web — How 0.5 ML golimumab 100 MG/ML Prefilled Syringe [Si... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
0.5 ML golimumab 100 MG/ML Prefilled Syringe [Simponi]
RxCUI 848164 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Golimumab
819300IN
-
Golimumab
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Simponi
848161BN
-
Simponi
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Golimumab Prefilled Syringe
848159SCDF -
Golimumab Injectable Product
1157808SCDG -
Golimumab Prefilled Syringe [Simponi]
848163SBDF -
Simponi Injectable Product
1182643SBDG -
Prefilled Syringe
721656DF -
Injectable Product
1151126DFG
-
Golimumab Prefilled Syringe
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
0.5 ML golimumab 100 MG/ML Prefilled Syringe
848160SCD -
Golimumab 100 MG/ML
848158SCDC -
Golimumab 100 MG/ML [Simponi]
848162SBDC
-
0.5 ML golimumab 100 MG/ML Prefilled Syringe
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
0.5 ML golimumab 100 MG/ML Prefilled Syringe
SCD · 848160 -
Golimumab 100 MG/ML
SCDC · 848158 -
Golimumab Prefilled Syringe
SCDF · 848159 -
Golimumab Injectable Product
SCDG · 1157808
Brand-Name Concepts
-
Golimumab 100 MG/ML [Simponi]
SBDC · 848162 -
Golimumab Prefilled Syringe [Simponi]
SBDF · 848163 -
Simponi Injectable Product
SBDG · 1182643 -
Simponi
BN · 848161
📦 FDA Products & Package NDCs
2 products · 8 package NDCs
8 package NDCs map to RxCUI 848164 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 57894-0070-01 | 1 SYRINGE, GLASS in 1 CARTON (57894-070-01) / .5 mL in 1 SY... | Simponi | Janssen Biotech, Inc. | 2009-04-25 |
| 57894-0070-02 | 1 SYRINGE in 1 CARTON (57894-070-02) / .5 mL in 1 SYRINGE | Simponi | Janssen Biotech, Inc. | 2009-04-25 |
| 57894-0070-89 | 1 SYRINGE in 1 CARTON (57894-070-89) / .5 mL in 1 SYRINGE | Simponi | Janssen Biotech, Inc. | 2009-04-25 |
| 57894-0070-90 | 1 SYRINGE, GLASS in 1 CARTON (57894-070-90) / .5 mL in 1 SY... | Simponi | Janssen Biotech, Inc. | 2009-04-25 |
| 57894-0071-01 | 1 SYRINGE, GLASS in 1 CARTON (57894-071-01) / 1 mL in 1 SYR... | Simponi | Janssen Biotech, Inc. | 2013-05-15 |
| 57894-0071-02 | 1 SYRINGE in 1 CARTON (57894-071-02) / 1 mL in 1 SYRINGE | Simponi | Janssen Biotech, Inc. | 2013-05-15 |
| 57894-0071-89 | 1 SYRINGE in 1 CARTON (57894-071-89) / 1 mL in 1 SYRINGE | Simponi | Janssen Biotech, Inc. | 2013-05-15 |
| 57894-0071-90 | 1 SYRINGE, GLASS in 1 CARTON (57894-071-90) / 1 mL in 1 SYR... | Simponi | Janssen Biotech, Inc. | 2013-05-15 |
Observed labelers:
Janssen Biotech, Inc. (8)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.